ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
IgGenix Announces $25M in Series A1 Funding firstwordpharma
July 28, 2021IgGenix, Inc., a biotechnology company taking a revolutionary approach to directly address allergic disease, today announced that it has raised $25 million in an oversubscribed Series A1 financing.
Pharma Sources Insight January 2025
